Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2011.0158


Sequencing Cancer Genome shapes new ways in surgical oncology.

Franco Roviello, M.D.

Affiliation: Professor Franco Roviello, Via A. De Gasperi, 5-53100 Siena, Italy

E-mail :

Progress in medical and surgical oncology has been slow. Overall survival and cure rates of patients with solid cancer have modestly been improved over the last decade despite the advent of targeted therapy. The advent of next-generation sequencing (NGS) technology allows now whole genome and exome sequencing for the identification of unbiased data about mutations underlying cancer. In addition, new high-throughput techniques provide insights and the role of epigenetic modification, miRNAs deregulation and transcriptome changes that drive tumorigenesis and metastasis.
These advances in understanding the structure and function of cancer genome are discussed here along with challenges to reach clinical implications in the multimodal and interdisciplinary treatment of cancer patients.

(Citation: Gastric & Breast Cancer 2011; 10(2): 109-115)



You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €33 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 17 March 2011